CervoMed Inc reports results for the quarter ended in January - Earnings Summary

CervoMed

09/08/2024 22:37

* CervoMed Inc  CRVO.OQ  reported a quarterly adjusted loss
of 27
cents​​ per share for the quarter ended in January.  The mean
expectation of five analysts for the quarter was for a loss
of 31 cents per share. Wall Street expected results to range
from -44 cents to -1 cents per share.
    * Revenue was $3.29 million​; analysts expected $2.20
million. 
    * CervoMed Inc's reported EPS for the quarter was a loss
of 27
cents​.
    * The company reported a quarterly loss of $2.32 million.
    * CervoMed Inc shares had fallen by 33.8% this quarter and
gained 48.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 27.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for CervoMed Inc is
$63.00 
This summary was machine generated from LSEG data August 9 at
09:36 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.31          -0.27          Beat
 Mar. 31 2024      -0.39          -0.41          Missed
 Dec. 31 2023      -0.29          -0.38          Missed
 Sep. 30 2023      -0.95          -0.70          Beat